[1] Siegel RL, Miller KD, Wagle NS, et al.Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48.
[2] Schulman BA, Harper JW.Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways[J]. Nat Rev Mol Cell Biol, 2009, 10(5): 319-331.
[3] Eldridge AG, O’brien T.Therapeutic strategies within the ubiquitin proteasome system[J]. Cell Death and Differentiation, 2010, 17(1): 4-13.
[4] Wilkinson KD.Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome[J]. Seminars in Cell & Developmental Biology, 2000, 11(3): 141-148.
[5] Peinado H, Olmeda D, cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?[J]. Nature Reviews Cancer, 2007, 7(6): 415-428.
[6] Guan T, Yang X, Liang H, et al.Deubiquitinating enzyme USP9X regulates metastasis and chemoresistance in triple-negative breast cancer by stabilizing Snail1[J]. Journal of Cellular Physiology, 2022, 237(7): 2992-3000.
[7] Bayraktar S, Barrera AMG, Liu D, et al.USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancer[J]. Cancer Journal, 2013, 19(1): 10-17.
[8] Li L, Deng T, Zhang L, et al.ERK-mediated Cytoplasmic Retention of USP11 Contributes to Breast Cancer Cell Proliferation by Stabilizing Cytoplasmic p21[J]. International Journal of Biological Sciences, 2022, 18(6): 2568-2582.
[9] Chen XS, Wang KS, Guo W, et al.UCH-L1-mediated down-regulation of estrogen receptor α contributes to insensitivity to endocrine therapy for breast cancer-University of Kentucky[J]. Theranostics, 2020, 10(4): 1833-1848.
[10] Liu S, González-Prieto R, Zhang M, et al.Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis[J]. Clinical Cancer Research, 2020, 26(6): 1460-1473.
[11] Kang Y, Siegel PM, Shu W, et al.A multigenic program mediating breast cancer metastasis to bone[J]. Cancer Cell, 2003, 3(6): 537-549.
[12] Wang X, Shi W, Shi H, et al.TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells[J]. J Exp Clin Cancer Res, 2016, 35(1): 100.
[13] 张婉莹. BAP1稳定TRIM11调控乳腺癌细胞增殖的研究[D]. 大连:大连理工大学, 2023.
[14] Karunarathna U, Kongsema M, Zona S, et al.OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance[J]. Oncogene, 2016, 35(11): 1433-1444.
[15] Liao GB, Li XZ, Zeng S, et al.Regulation of the master regulator FOXM1 in cancer[J]. Cell Communication and Signaling, 2018, 16(1): 57.
[16] 牟丽颖. 去泛素化酶JOSD1对乳腺癌细胞增殖的影响研究[D]. 大连:大连理工大学, 2021.
[17] Clark SL, Rodriguez AM, Snyder RR, et al.Structure-Function Of The Tumor Suppressor BRCA1[J]. Comput Struct Biotechnol J, 2012, 1(1): e201204005.
[18] 郭雪媛. USP4调控BRCA1蛋白稳定性的作用机制及其与乳腺癌发生发展的关系[D]. 北京:北京大学医学部, 2023.
[19] Zhao GY, Lin ZW, Lu CL, et al.USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma[J]. Tumour Biology, 2015, 36(3): 1721-1729.
[20] Mcconnell BB, Yang VW.Mammalian Krüppel-like factors in health and diseases[J]. Physiological Reviews, 2010, 90(4): 1337-1381.
[21] 王雪. 去泛素化酶USP7对乳腺癌细胞增殖的调控作用[D]. 大连:大连理工大学, 2023.
[22] Pu Q, Lv YR, Dong K, et al.Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells[J]. BMC Cancer, 2020, 20(1): 583.
[23] Zhou T, Wu Y, Qian D, et al.OTUD1 chemosensitizes triple-negative breast cancer to doxorubicin by modulating P16 expression[J]. Pathol Res Pract, 2023, 247: 154571.
[24] Serra S, Chetty R. p16[J]. Journal of Clinical Pathology, 2018, 71(10): 853-858.
[25] D’arcy P, Brnjic S, Olofsson MH, et al.Inhibition of proteasome deubiquitinating activity as a new cancer therapy[J]. Nature Medicine, 2011, 17(12): 1636-1640.
[26] Valacchi G, Pecorelli A, Sticozzi C, et al.Rottlerin exhibits antiangiogenic effects in vitro[J]. Chemical Biology & Drug Design, 2011, 77(6): 460-470.
[27] Peng Z, Wang Y, Fan J, et al.Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway[J]. Scientific Reports, 2017, 7: 41254.
[28] Vogel RI, Coughlin K, Scotti A, et al.Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells[J]. Oncotarget, 2015, 6(6): 4159-4170.
[29] 李欣茹, 王嘉琦, 柯细松, 等. 薯蓣皂苷靶向泛素-蛋白酶体的抗肿瘤活性研究[J]. 肿瘤防治研究, 2023, 50(6): 567-572. |
